These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33502288)

  • 1. Cardiac biomarkers for risk stratification of arrhythmic death in patients with heart failure and reduced ejection fraction.
    Burger AL; Stojkovic S; Diedrich A; Wojta J; Demyanets S; Pezawas T
    Br J Biomed Sci; 2021 Oct; 78(4):195-200. PubMed ID: 33502288
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.
    Sabatine MS; Morrow DA; de Lemos JA; Omland T; Sloan S; Jarolim P; Solomon SD; Pfeffer MA; Braunwald E
    Circulation; 2012 Jan; 125(2):233-40. PubMed ID: 22179538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.
    Shah RV; Truong QA; Gaggin HK; Pfannkuche J; Hartmann O; Januzzi JL
    Eur Heart J; 2012 Sep; 33(17):2197-205. PubMed ID: 22645194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.
    Holm H; Nägga K; Nilsson ED; Ricci F; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A
    J Intern Med; 2017 Jul; 282(1):94-101. PubMed ID: 28407377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
    Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
    Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure.
    Arfsten H; Bartko PE; Pavo N; Heitzinger G; Mascherbauer J; Hengstenberg C; Hülsmann M; Goliasch G
    Eur J Clin Invest; 2019 Nov; 49(11):e13159. PubMed ID: 31356682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
    Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
    Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
    Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Elmas E; Doesch C; Fluechter S; Freundt M; Weiss C; Lang S; Kälsch T; Haghi D; Papassotiriou J; Kunde J; Schoenberg SO; Borggrefe M; Papavassiliu T
    Int J Cardiovasc Imaging; 2011 Apr; 27(4):547-56. PubMed ID: 20872251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
    Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study.
    Schnabel RB; Wild PS; Schulz A; Zeller T; Sinning CR; Wilde S; Kunde J; Lubos E; Lackner KJ; Warnholtz A; Gori T; Blankenberg S; Munzel T;
    Hypertension; 2012 Aug; 60(2):288-95. PubMed ID: 22689741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
    Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.
    Truong QA; Siegel E; Karakas M; Januzzi JL; Bamberg F; Mahabadi AA; Dasdemir S; Brady TJ; Bergmann A; Kunde J; Nagurney JT; Hoffmann U; Koenig W
    Clin Chem; 2010 Apr; 56(4):651-60. PubMed ID: 20185624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular biomarkers predict fragility fractures in older adults.
    Johansson M; Ricci F; Di Martino G; Rogmark C; Sutton R; Hamrefors V; Melander O; Fedorowski A
    Heart; 2019 Mar; 105(6):449-454. PubMed ID: 30322844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
    Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
    Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.